### LINC02365 Gene Overview

**Gene Symbol**: LINC02365  
**Type**: Long Intergenic Non-Protein Coding RNA  
**Location**: Human chromosome (specific location may vary based on assembly)  

#### Summary
LINC02365 is a long non-coding RNA (lncRNA) that has been identified in various studies focusing on gene regulation and cellular processes. Unlike protein-coding genes, lncRNAs play crucial roles in regulating gene expression at transcriptional and post-transcriptional levels.

### 1. Associated Genes
While there might not be a comprehensive list of genes specifically associated with LINC02365 provided in NCBI or UniProt summaries, ongoing research typically highlights various interactions with functional gene networks, especially those involved in non-coding RNAs and regulatory mechanisms. Potentially associated genes based on common pathways include:

- **TP53**: Traditionally linked to lncRNA regulation and cancer.
- **MYC**: Known to be influenced by lncRNA networks, especially in the context of tumorigenesis.
- **C-MYC**: Similar to MYC, often involved in cellular proliferation and regulation.

Further research may reveal more detailed associations particularly in the context of transcriptome-wide interactions.

### 2. Aging and Age-Related Diseases
Studies on LINC02365 and its role in aging and age-related diseases are limited but may suggest the following:

- Research indicates that lncRNAs play roles in cellular senescence, which is a significant factor in aging.
- LINC02365 could be implicated in pathways that impact cellular functions over time, although definitive links between this gene and specific age-related diseases (such as Alzheimer’s or cardiovascular diseases) remain to be fully elucidated.

Ongoing investigations may reveal its association with age-related pathological conditions potentially affecting gene regulation in those scenarios.

### 3. Drug Interactions
Currently, there is limited information specifically associating LINC02365 with any particular drugs or drug classes. However, as research in lncRNAs and pharmacogenomics expands, it's possible that future studies will identify potential interactions. Some areas to consider may include:

- **Cancer therapeutics**: If LINC02365 is found to be involved in oncogenesis, targeted therapies that modulate lncRNA expression may indirectly affect its function.
- **Epigenetic modifying drugs**: These could potentially impact the expression and function of LINC02365 through alterations in chromatin structure or transcriptional regulation.

### 4. Involved Pathways and Biological Processes
LINC02365 likely participates in a variety of biological processes, potentially including:

- **Regulation of Gene Expression**: As an lncRNA, it may influence the transcriptional regulation of nearby or distant genes.
- **Cell Cycle Control**: Given the association of lncRNAs with cell proliferation, LINC02365 could play a role here.
- **Cellular Responses to DNA Damage**: LncRNAs are often implicated in responding to stress and may modulate cellular repair mechanisms.

Further research may specifically identify pathways that include:

- **Wnt Signaling Pathway**
- **Epithelial-Mesenchymal Transition (EMT)** and pathways associated with cancer metastasis, should connections to oncogenic processes be established.

### Conclusion
While LINC02365 is recognized as a long non-coding RNA with potential regulatory functions, ongoing research is required to delineate its exact roles, associations, and implications in health, aging, and disease. The evolving field of lncRNA biology promises to enrich our understanding of such genes and their relevance in various biological contexts.